Treatment of the common cold

BMJ

Volumn 317, Issue 7150, 1998, Pages 33-

  Mossad, Sherif B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; ZINC; ANTIINFECTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERFERON; ZINC DERIVATIVE;

COMMON COLD; DROWSINESS; EPISTAXIS; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MAST CELL; NOSE IRRITATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RHINOVIRUS; SIDE EFFECT; SYMPTOM; WATER VAPOR; DRUG COMBINATION;

ADRENERGIC ALPHA-AGONISTS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; ASCORBIC ACID; CHOLINERGIC ANTAGONISTS; COMMON COLD; DRUG COMBINATIONS; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERFERONS; ZINC COMPOUNDS;

EID: 0032482578     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.317.7150.33     Document Type: Article

References (49)

1. Eccles R Van Cauwenberge P Tetzloff W Borum P.A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate in the relief of runny nose and sneezing associated with upper respiratory tract infection.J Pharm Pharmacol 1995;47:990–993.
2. Gwaltney Jr JM Park J Paul RA Edelman DA O'Connor RR Turner RB.Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.Clin Infect Dis 1996;22:656–662.
3. Howard Jr JC Kantner TR Lilienfield LS Princiotto JV Krum RE Crutcher JE et al. Effectiveness of antihistamines in the symptomatic management of the common cold.JAMA 1979;242:2414–2417.
4. Gaffey MJ Kaiser DL Hayden FG.Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms.Pediatr Infect Dis J 1988;7:223–228.
5. Borum P Olsen L Winther B Mygind N.Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold.Am Rev Respir Dis 1981;123:418–420.
6. Diamond L Dockhorn RJ Grossman J Kisicki JC Posner M Zinny MA et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold.J Allergy Clin Immunol 1995;95:1139–1146.
7. Hayden FG Diamond L Wood PB Korts DC Wecker MT.Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial.Ann Intern Med 1996;125:89–97.
8. Akerlund A Klint T Olen L Rundcrantz H.Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients.J Laryngol Otol 1989;103:743–746.
9. Sperber SJ Sorrentino JV Riker DK Hayden FG.Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.Bull NY Acad Med 1989;65:145–160.
10. Ophir D Elad Y.Effects of steam inhalation on nasal patency and nasal symptoms in patients with the common cold.Am J Otolaryngol 1987;3:149–153.
11. Tyrrell D Barrow I Arthur J.Local hyperthermia benefits natural and experimental common colds.BMJ 1989;289:1280–1283.
12. Forstall GJ Macknin ML Yen-Lieberman B Medendorp SV.Effect of inhaling heated vapor on symptoms of the common cold.JAMA 1994;271:1109–1111.
13. Hendley JO Abott RD Beasley PP Gwaltney Jr JM.Effect of inhalation of hot humidified air on experimental rhinovirus infection.JAMA 1994;271:1112–1113.
14. Barrow GI Higgins PG Al-Nakib W Smith AP Wenham PBM Tyrrell AJ.The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers.Clin Exp Allergy 1990;20:45–51.
15. Aberg N Aberg B Alestig K.The effect of inhaled and intranasal sodium cromoglycate on symptoms of upper respiratory tract infections.Clin Exp Allergy 1996;26:1045–1050.
16. Stanley ED Jackson GG Panusarn C Rubenis M Dirda V.Increased virus shedding with aspirin treatment of rhinovirus infection.JAMA 1975;231:1248–1251.
17. Graham NMH Burrell CJ Douglas RM Debelle P Davies L.Adverse effects of aspirin, acetaminophen and ibuprofen on immune function, viral shedding and clinical status in rhinovirus-infected volunteers.J Infect Dis 1990;162:1277–1282.
18. Sperber SJ Hendley O Hayden FG Riker DK Sorrentino JV Gwaltney Jr JM.Effects of naproxen on experimental rhinovirus colds: a randomized, double-blind, controlled trial.Ann Intern Med 1992;117:37–41.
19. Chalmers TC.Effects of ascorbic acid on the common cold: an evaluation of the evidence.Am J Med 1975;58:532–536.
20. Hemila H Herman ZS.Vitamin C and the common cold: a retrospective analysis of Chalmers' review.J Am Coll Nutr 1995;14:116–123.
21. Hemila H.Does vitamin C alleviate the symptoms of the common cold? A review of current evidence.Scand J Infect Dis 1994;26:1–6.
22. Farr BM Gwaltney Jr JM Hendley JO Hayden FG Naclerio RM McBride T et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.J Infect Dis 1990;162:1173–1177.
23. Gustafson LM Proud D Hendley JO Hayden FG Gwaltney Jr JM.Oral prednisone therapy in experimental rhinovirus infections.J Allergy Clin Immunol 1996;97:1009–1014.
24. Gonzales R Steiner JF Sande MA.Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis by ambulatory care physicians.JAMA 1997;278:901–904.
25. Mainous III AG Hueston WJ Clark JR.Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Pract 1996;42:357–361.
26. Kaiser L Lew D Hirschel B Auckenthaler R Morabia A Heald A et al. Effects of antibiotic treatment in the subset of common cold patients who have bacteria in nasopharyngeal secretions.Lancet 1996;347:1507–1510.
27. Potter YJ Hart LL.Zinc lozenges for treatment of common colds.Ann Pharmacother 1993;27:589–592.
28. Mossad SB Macknin ML Medendorp SV Mason P.Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study.Ann Intern Med 1996;125:81–88.
29. Farr BM Gwaltney Jr.JM. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold.J Chron Dis 1987;40:875–879.
30. Novick SG Godfrey JC Godfrey NJ Wlder HR.How does zinc modify the common cold? Clinical observation and implications regarding mechanism of action.Med Hypotheses 1996;46:295–302.
31. Farr BM Gwaltney Jr JM Adams KF Hayden FG.Intranasal interferon-2 for prevention of natural rhinovirus colds.Antimicrob Agents Chemother 1984;26:31–34.
32. Samo TC Greenberg SB Couch RB Quarles J Johnson PE Hook S et al. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.J Infect Dis 1983;148:535–542.
33. Hayden FG Osterhaus ADME Treanor JJ Fleming DM Aoki FY Nicholson KG et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections.N Engl J Med 1997;337:874–880.
34. Al-Nakib W Higgins PG Barrow GI Tyrrell DAJ Andries K Vanden Bussche G et al. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).Antimicrob Agents Chemother 1989;33:522–525.
35. Hayden FG Hipskind GJ Woerner DH Eisen GF Janssens M Janssen PAJ et al. Intranasal Pirodavir (R77,975) treatment of rhinovirus colds.Antimicrob Agents Chemother 1995;39:290–294.
36. Dolovich MB Mahony JB Chambers C Newhouse MT Chernesky MA.Ciliary function, cell viability and in vitro effect of ribavirin on nasal epithelial cells in acute rhinorrhea.Chest 1992;102:284–287.
37. McKinlay MA Pevear DC Rossmann MG.Treatment of the picornavirus common colds by inhibitors of viral uncoating and attachment.Annu Rev Microbiol 1992;46:635–654.
38. Doyle WJ Riker DK McBride TP Hayden FG Hendley JO Swarts JD et al. Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds.Ann Otol Rhinol Laryngol 1993;102:521–527.
39. Clemens CJ Taylor JA Almquist JR Quinn HC Mehta A Naylor GS.Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preshcool children? J Pediatr 1997;130:463–466.
40. Smith MB Feldman W.Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991.JAMA 1993;269:2258–2263.
41. Gwaltney Jr JM Moskalski PB Hendley JO.Interruption of experimental rhinovirus transmission.J Infect Dis 1980;142:811–815.
42. Kuhn JJ Hendley JO Adams KF Clark JW Gwaltney Jr JM.Antitussive effect of guaifenesin in young adults with natural colds: objective and subjective assessment.Chest 1982;82:713–718.
43. Kirkpatrick GL.The common cold.Primary Care 1996;23:657–675.
44. Lowenstein SR Parrino TA.Management of the common cold.Adv Intern Med 1987;32:207–234.
45. Gwaltney JM Buier RM Rogers JL.The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold.Antiviral Research 1996;29:287–295.
46. English JA Mauman KA.Evidence-based management of upper respiratory infection in a family practice teaching clinic.Fam Med 1997;29:38–41.
47. Roberts CR Imrey PB Turner JD Hosokawa MC Alster JM.Reducing physician visits for colds through consumer education.JAMA 1983;250:1986–1989.
48. Maiman LA Becker MH Cummings KM Drachman RH O'Connor PA.Effects of sociodemographic and attitudinal factors on mother-initiated medication behavior for children.Public Health Reports 1982;97:140–149.
49. Litovitz TL Smilkstein M Felberg L Klein-Schwartz W Berlin R Morgan JL.1996 Annual report of poison control centers toxic exposure surveillance system.Am J Emerg Med 1997;15:447–500.